BHC Bausch Health Companies Inc.: יחס שווי שוק לערך בספרים

Bausch Health Companies (BHC) is a global player whose expansion is based on patent ownership and an extensive distribution network, which reduces costs during mass production. The business is developing a comprehensive environment in dermatology and gastroenterology, creating complex treatment protocols. Meanwhile, Bausch Health Companies (BHC) is fighting for niches in ophthalmology and GI to minimize the impact of debt and price dumping. The indicator stands at -1.34, which is confirmed by this price chart serving as a validation of the market valuation.

This indicator compares the current market value of Bausch Health Companies (BHC) with its net assets, revealing the extent to which the business is overvalued or undervalued relative to its book value. Given the holding's high debt load analyzed by GURU.Markets, the market-to-book ratio clarifies how effectively the inertial cash flow from mature products can sustain the company's real value amidst market volatility.